Introduction
The trade-off question at hand is whether Insightec should prioritize expanding its Exablate Neuro system's indications or focus on improving treatment efficacy for existing approved conditions. This scenario involves balancing growth through new applications versus enhancing core offerings. I'll analyze this trade-off by examining product understanding, potential impacts, key metrics, and experimental approaches to inform a strategic recommendation.
I'd like to outline my approach to ensure we're aligned on the key areas I'll be covering in my analysis.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps assess the urgency of expansion vs. improvement Expected answer: Market leader with 60-70% share, 2-3 main competitors Impact: High market share might favor efficacy focus, while strong competition could push for expansion
Why it matters: Influences financial viability of expansion Expected answer: Higher reimbursement for certain new indications Impact: Favorable rates for new indications would support expansion strategy
Why it matters: Indicates urgency of efficacy improvements Expected answer: 80-85% satisfaction rate Impact: Lower satisfaction would prioritize efficacy improvements
Why it matters: Affects feasibility of each option Expected answer: 2-3 years for new indications, 1-2 years for improvements Impact: Shorter timelines might favor the quicker option
Why it matters: Determines feasibility of parallel efforts Expected answer: Team at 80% capacity, limited bandwidth for new projects Impact: High utilization might necessitate choosing one focus area
Practice similar questions
Subscribe to access the full answer